These findings uncover a previously unrecognized role of the MSL complex in regulating CD274, linking MSL1 to immune checkpoint control, apoptosis, and modulation of the tumor microenvironment, and highlighting it as a potential target to enhance tumor immunotherapy. Here, CD274 is linked to neoplasm.